Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-13

Clinical Trial Update: Comparison of Trough Level- and Clinical-based Spacing of Infliximab Infusions in Patients With IBD in Deep Remission [NA]

View source ↗

Summary

This update reports a terminated clinical trial comparing trough-level–based spacing to clinically based spacing of infliximab infusions in patients with inflam…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remicade (infliximab)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Inflammatory Bowel Diseases | NA | Status: TERMINATED